Case Report

Ferrous Sulfate‐Induced Increase in Requirement for Thyroxine in a Patient With Primary Hypothyroidism

Authors: K. M. MOHAMED SHAKIR MD, JOHN P. CHUTE MD, BRIAN S. APRILL MD, ANGELINE A. LAZARUS MD

Abstract

ABSTRACTRecent studies have shown that under experimental conditions ferrous sulfate may reduce the gastrointestinal absorption of orally administered levothyroxine sodium in patients with primary hypothyroidism. We describe a patient who became hypothyroid while taking ferrous sulfate. The hypothyroid status was corrected by increasing die dose of levothyroxine. Subsequently, when ferrous sulfate was discontinued, die patient became hyperthyroid while taking die higher dose of thyroid hormone preparation. Since both hypothyroidism and iron deficiency anemia may coexist, additional thyroid function testing is recommended in patients treated concurrently with ferrous sulfate and L-thyroxine.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References